ATE306937T1 - Impfstoff gegen tumore der b-lymphozyten - Google Patents

Impfstoff gegen tumore der b-lymphozyten

Info

Publication number
ATE306937T1
ATE306937T1 AT97905966T AT97905966T ATE306937T1 AT E306937 T1 ATE306937 T1 AT E306937T1 AT 97905966 T AT97905966 T AT 97905966T AT 97905966 T AT97905966 T AT 97905966T AT E306937 T1 ATE306937 T1 AT E306937T1
Authority
AT
Austria
Prior art keywords
vaccine against
lymphocyte tumors
vaccine
lymphocyte
tumors
Prior art date
Application number
AT97905966T
Other languages
English (en)
Inventor
Mircea C Popescu
Larry Kwak
Augusto C Ochoa
Larry Boni
Original Assignee
Biomira Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomira Usa Inc filed Critical Biomira Usa Inc
Application granted granted Critical
Publication of ATE306937T1 publication Critical patent/ATE306937T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97905966T 1996-02-16 1997-02-13 Impfstoff gegen tumore der b-lymphozyten ATE306937T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1178396P 1996-02-16 1996-02-16
PCT/US1997/002351 WO1997029769A1 (en) 1996-02-16 1997-02-13 Vaccine for b-cell malignancies

Publications (1)

Publication Number Publication Date
ATE306937T1 true ATE306937T1 (de) 2005-11-15

Family

ID=21751949

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97905966T ATE306937T1 (de) 1996-02-16 1997-02-13 Impfstoff gegen tumore der b-lymphozyten

Country Status (8)

Country Link
US (2) US6312718B1 (de)
EP (1) EP0918539B1 (de)
JP (1) JP3948751B2 (de)
AT (1) ATE306937T1 (de)
AU (1) AU2273497A (de)
CA (1) CA2246708C (de)
DE (1) DE69734392T2 (de)
WO (1) WO1997029769A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1523977A1 (de) * 1997-10-01 2005-04-20 Biomira Usa Inc. Biologisch aktive Verbindungen enthaltende multilamellare Koaleszenzvesikel (MLCV)
IN190388B (de) * 1997-10-01 2003-07-26 Biomira Usa Inc
CA2318557A1 (en) 1998-01-16 1999-07-22 Biomira Usa Inc. Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes
CA2318556A1 (en) * 1998-01-16 1999-07-22 Biomira, Inc. Lipomatrix preparation
DE19954843C2 (de) * 1999-11-09 2003-11-20 Novosom Ag Verfahren zur Verkapselung von Proteinen oder Peptiden in Liposomen, mit dem Verfahren hergestellte Liposomen und deren Verwendung
US6911204B2 (en) 2000-08-11 2005-06-28 Favrille, Inc. Method and composition for altering a B cell mediated pathology
SG143058A1 (en) * 2000-08-11 2008-06-27 Favrille Inc Method and composition for altering a t cell mediated pathology
US20060029655A1 (en) * 2001-06-25 2006-02-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method for preparation of vesicles loaded with biological material and different uses thereof
FR2934498B1 (fr) * 2008-08-01 2014-08-15 Commissariat Energie Atomique Utilisation d'une forme soluble d'hla-g dans le traitement des proliferations anormales des lymphocytes b.
US8647627B2 (en) 2011-01-13 2014-02-11 Oncbiomune, L.L.C. Composition for a cancer vaccine
WO2014036488A1 (en) 2012-08-31 2014-03-06 Biovest International, Inc. Methods for producing high-fidelity autologous idiotype vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036945A (en) 1976-05-03 1977-07-19 The Massachusetts General Hospital Composition and method for determining the size and location of myocardial infarcts
US4331647A (en) 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
ATE147633T1 (de) * 1988-10-27 1997-02-15 Univ Minnesota Immunhilfsmittel aus liposome enthaltend lymphokin il -2
AU5361794A (en) * 1992-10-14 1994-05-09 Board Of Trustees Of The Leland Stanford Junior University Enhancement of b cell lymphoma tumor resistance using idiotype/cytokine conjugates
US5861158A (en) * 1993-11-17 1999-01-19 The United States Of America As Represented By The Deptartment Of Health And Human Services Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor

Also Published As

Publication number Publication date
JP3948751B2 (ja) 2007-07-25
EP0918539B1 (de) 2005-10-19
JP2000507214A (ja) 2000-06-13
US20030021838A1 (en) 2003-01-30
EP0918539A1 (de) 1999-06-02
US6312718B1 (en) 2001-11-06
DE69734392T2 (de) 2006-07-13
CA2246708A1 (en) 1997-08-21
AU2273497A (en) 1997-09-02
CA2246708C (en) 2005-06-14
WO1997029769A1 (en) 1997-08-21
DE69734392D1 (de) 2006-03-02
EP0918539A4 (de) 2001-04-11

Similar Documents

Publication Publication Date Title
AU709406C (en) Combined vaccines comprising hepatitis B surface antigen and other antigens
AU4518196A (en) Adjuvant-incorporated cellular antigens: conjugation and methods
IL114444A (en) Kit for inducing immune response against a tumor or a disease caused by an infectious agent
DE69734392D1 (de) Impfstoff gegen tumore der b-lymphozyten
IL125608A0 (en) Tumor associated antigen peptides and use of same as anti-tumor vaccines
ATE422352T1 (de) Liposomaler grippeimpfstoff und verfahren
ATE298367T1 (de) Interleukin-15 antagoniste
EP0958364A4 (de) Immuntherapie und verbesserte impfstoffe
NO992156D0 (no) Acellulµr kikhostevaksine med difteri- og tetanus-toksoider
IT238082Y1 (it) Gruppo motore doppio per la movimentazione di schienale e poggiapiediin poltrone e simili
ITBZ950002A0 (it) Dispositivo per la rotazione di pezzi mossi in avanti e disposti di piatto.
NZ511445A (en) Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects
AU2247095A (en) Cellular immune response-specific antigens and uses therefor
IT1217803B (it) Copoliestrere termotropico e procedimento per la sua preparazione e suo uso
AU7245296A (en) Mhc-class ii restricted melanoma antigens and their use in therapeutic methods
NO934106L (no) Liposome polysakkarid-vaksiner
IL81920A (en) Vaccines comprising an antigen and interferon-ypsilon and their preparation
IT1217177B (it) Palmitoil-fruttosio-1,6-difosfato,suo uso terapeutico e relativi metodi di preparazione
FI913530A7 (fi) Ekskretorisia/sekretorisia heisimato-(Cysticercus cellulosae)-antigeen eja, jotka ovat tarkoitetut käytettäviksi immunodiagnoosissa ja rokote valmisteessa
IT9067670A1 (it) Medicamento a base di anamelide, particolarmente utile nella terapia delle ustioni e simili
IT221102Z2 (it) Dispositivo per colture in vaso e simili
BR1100913A (pt) Vacinas combinadas compreendendo o antìgeno superficial da hepatite b e outros antìgenos
IT217034Z2 (it) Struttura di sopporto per sedie e simili
KR960019880U (ko) 탁자에 결합된 이동의자
ITCS940004A0 (it) Dispositivo di origliere (guanciale) mobile e rimovibile per poltrone

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties